[ Inside the business ]

MO stock analysis

MO · Altria Group, Inc.

Cigarettes. Growing 1%. Keeps 47¢ of every dollar.

Nothing unusual in its latest filings.

The future, in 7 questions

Priced in: 2.1× sales in 5 yrs. Evidence: sales +1% · 47¢ profit/$1.

01 What's priced in?2.1× sales in 5 yrs
Sales now$23.5B
Needed in 5 yrs$50.2B
02 Is the wave rising?No Radar technology matched

Not among the companies mentioning Radar's technologies most.

03 Will customers keep buying?Customer One: 23% of sales
Customer One 23%Customer Two 19%Everyone else
Prepaid $165MSales +1%, steady
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Keeps 47¢ per $1
'21'22'23'24'2547¢
Before running costs: 57% → 62%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares −2.7%/yrDebt $24.1B
07 What could break it?Nothing flagged

✓ All clear

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth speeding up.

Sales growth +3%, +0%, then +1% vs. a year ago.

What could go wrong

Steadier than most.

It has moved 0.5× the market. In the 2008 crisis it fell 26% while the market fell 51%. Debt is moderate.

Speculative check

Self-funding.

Passes every condition: profitable, cash-generating and financially sound.

What they sell

89% Smokeable Products Segment.

Smokeable Products Segment 89% · Oral Tobacco Segment 11% · Other Operating Segment 0% (latest quarter)

Where each dollar goes

47¢ profit.

24¢ to make what it sells, 29¢ on research and overhead, 47¢ left over. Revenue $23.5B in the last 12 months.

Its market

-1.4× the economy.

The government expects its industry, tobacco manufacturing, to grow -2.7% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Maturity.

It earns cash, still invests, and pays back more than it borrows.

Earnings quality

Can't score.

Not available: some of the eight inputs aren't in the company's structured filings (common for banks, insurers and companies without a cost of goods line).

Competitive advantage

10 of 10 years.

Returns beat its 7.1% cost of capital in 10 of the last 10 years. Gross margin went from 45% to 62%.

Future bets

1% on research.

$195M a year on R&D. $351M on equipment and buildings.

All figures from Altria Group, Inc.'s SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.